Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong
· Delayed Price · Currency is HKD 1.120
-0.030 (-2.61%)
Apr 29, 2026, 4:08 PM HKT
HKG:0950 Revenue
In the year 2025, Lee's Pharmaceutical Holdings had annual revenue of 1.44B HKD with 2.57% growth. Lee's Pharmaceutical Holdings had revenue of 741.16M in the half year ending December 31, 2025, with 37.07% growth.
Revenue
1.44B
Revenue Growth
+2.57%
P/S Ratio
0.46
Revenue / Employee
1.39M
Employees
1,036
Market Cap
659.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.44B | 36.01M | 2.57% |
| Dec 31, 2024 | 1.40B | 346.94M | 32.95% |
| Dec 31, 2023 | 1.05B | -180.11M | -14.61% |
| Dec 31, 2022 | 1.23B | -33.01M | -2.61% |
| Dec 31, 2021 | 1.27B | 49.44M | 4.06% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 1.93B |
| China NT Pharma Group Company | 26.88M |
| Pak Fah Yeow International | 214.28M |
| Fusen Pharmaceutical Company | 304.20M |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.00B |
| Dawnrays Pharmaceutical (Holdings) | 1.37B |
| Essex Bio-Technology | 1.81B |